News in the Life Sciences Industry

OSLO, Norway, Nov. 30, 2020 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) announces that the Company's ticker symbol on the Oslo Børs will change from 'NANO' to 'NANOV' and will be effective as of the start of trading on 30 November 2020.

Safety Monitoring Committee review of first dose-level cohort allows progression of RAD-18-001 study to second dose level cohort

STOCKHOLM, Nov. 30, 2020 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm, ONCO), a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases, today announces that the number of shares and votes in Oncopeptides has changed... Read more ››

GÖTEBORG, Sweden, Nov. 30, 2020 /PRNewswire/ -- Today, Zlatko Rihter assumes his position as President and CEO of Mölnlycke.

STOCKHOLM, Nov. 27, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has submitted an application for market approval for the drug candidate Sedaconda (isoflurane), formerly known as IsoConDa, for inhaled sedation in intensive care. The... Read more ››

STOCKHOLM, Nov. 27, 2020 /PRNewswire/ -- Calliditas Therapeutics AB (publ.) publishes the nomination committee's composition for the AGM in 2021.

HELSINKI, Nov. 27, 2020 /PRNewswire/ -- Strong momentum continues: first GMP campaign initiated, first dosing in humans to start before year-end, all near-term business targets set out in IPO to be achieved ahead of schedule, new global major pharma client signed, two new PoC projects started,... Read more ››

LINKÖPING, Sweden, Nov. 27, 2020 /PRNewswire/ -- Demand for the international medical imaging IT and cybersecurity company Sectra's... Read more ››

LUND, Sweden, Nov. 27, 2020 /PRNewswire/ -- BioInvent International AB ("BioInvent") (OMXS: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, announced today the appointment of Cecilia Hofvander... Read more ››

LUND, Sweden, Nov. 27, 2020 /PRNewswire/ -- BioInvent International AB's (publ) ("BioInvent") (OMXS: BINV) Extraordinary General Meeting (the "EGM") today resolved to approve the Board of Directors' resolution on a directed issue of 29,395,311 new shares and 14,697,655 new warrants... Read more ››

HELSINKI, Nov. 27, 2020 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, today announced a proprietary technology that can form biological nanoparticles as small as 50 nm and announced a new near-term business target for 2021 to... Read more ››

STOCKHOLM, Nov. 26, 2020 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that Gustaf Salford has been appointed to the role of President and CEO, effective immediately. He has been Acting CEO since early June 2020.

STOCKHOLM, Nov. 26, 2020 /PRNewswire/ -- In Elekta's second quarter, we managed to perform better than the overall radiotherapy market both in terms of orders and revenue despite continuous challenging circumstances. We also improved margins and stabilized cash flow. The launch of our new... Read more ››

STOCKHOLM, Nov. 26, 2020 /PRNewswire/ -- IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced an exclusive distribution agreement with KM Innovations BV, a leading distributor of world-class neurosurgical... Read more ››

LUND, Sweden, Nov. 26, 2020 /PRNewswire/ -- Cantargia AB (OMXS: CANTA) and BioInvent International AB (OMXS: BINV), today announced that BioInvent has been contracted as manufacturer of Cantargia's antibody CAN10 in preclinical development for the treatment of systemic sclerosis and myocarditis.... Read more ››

STOCKHOLM, Nov. 26, 2020 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) ("InDex") today announced that the company will host a virtual R&D day on Tuesday December 8, 2020 for investors, analysts and media.